-

Physician-researcher Dr. Kenar D. Jhaveri given Mid-Career Distinguished Leader Award by American Society of Nephrology

original (Photo: Business Wire)

(Photo: Business Wire)

MANHASSET, N.Y.--(BUSINESS WIRE)--For his dedication to clinical research, leadership and advancing the field of nephrology, Kenar D. Jhaveri, MD, will be honored with the American Society of Nephrology Distinguished Leader Award. The award will be presented to the Northwell Health nephrologist and researcher at The Feinstein Institutes for Medical Research in November 2023 during the ASN Kidney Week Conference in Philadelphia, PA. His recognition is the first for a Northwell physician.

As a physician-scientist, Dr. Jhaveri, professor of medicine and associate chief in the Division of Kidney Diseases and Hypertension at Northwell Health, has authored many highly- cited publications in the field of glomerular diseases, onconephrology and COVID-19 related kidney injury. His clinical and research interests are in glomerular diseases and onconephrology – cancer and its effect on the kidney.

The American Society of Nephrology (ASN) represents more than 21,000 kidney health professionals working to help people with kidney disease. Now in its fifth year, the Mid-Career Distinguished Leader award annually recognizes individuals who have demonstrated exceptional leadership qualities and outstanding contributions to the field of nephrology, “leading the fight against kidney disease.”

“Being a recipient of the ASN Distinguished Leader Award is an incredible honor, and I am immensely grateful to the society for recognizing my contributions to our field,” said Dr. Jhaveri, who is also faculty at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. “I am eager to continue my research to better advance treatment and care in the field of nephrology.”

Dr. Jhaveri is a founding member and past president of the American Society of Onconephrology and a founding member of the International Society of Glomerular Diseases. He serves as the editor-in-chief for the ASN’s journal, ASN Kidney News. In 2021, Dr. Jhaveri won the National Kidney Foundation’s New York- Excellence in Care Award.

During the COVID-19 pandemic, Dr. Jhaveri and his team were the first to recognize and publish data on acute kidney injury during its early months of hospitalizations and more recently, Northwell Health received a $1.25 million endowment gift to fund the newly created Galdi Fellowship in Onco-Nephrology and Glomerular Kidney Diseases, which will begin in July with Dr. Jhaveri as the fellowship program director.

“We congratulate Dr. Jhaveri for his recognition as a leader by the ASN,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. “As a highly respected physician-researcher, Dr. Jhaveri’s career work is advancing knowledge which will directly benefit patients with kidney disease.”

Dr. Jhaveri will continue to work towards his ongoing mission of advancing knowledge in the field of nephrology and improving the outcomes for patients with kidney disease and related conditions.

About the Feinstein Institutes
The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

Contacts

Julianne Mosher Allen
516-880-4824
jmosherallen@northwell.edu

Industry:

Northwell Health

Release Versions
English

Contacts

Julianne Mosher Allen
516-880-4824
jmosherallen@northwell.edu

More News From Northwell Health

Northwell to Launch Long Island’s First Pancreas Transplant Program

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health has received approval to launch Long Island’s first adult pancreas transplant program, according to a letter from the New York State Department of Health (DOH). The Northwell Transplant Institute at North Shore University Hospital (NSUH) recently hosted a site visit with DOH officials, the final hurdle before opening the program to new patients. Northwell’s pancreas program will open access to patients across the greater New York and southern C...

32BJ Health Fund and Northwell Direct Announce Largest Direct Healthcare Contract of its Kind in the Country, Delivering Major Savings and Expanding Access to Care

NEW YORK--(BUSINESS WIRE)--32BJ Health Fund, the union health fund representing 100,000 building service workers in the New York metro area, and Northwell Direct, a direct-to-employer health care network that partners directly with employers and labor unions to provide health benefits solutions to their employees, today announced a historic deal that will significantly expand access to high-quality care for 32BJ members and their families while delivering dramatic savings to patients, unions an...

Feinstein Institutes’ Researchers Develop Promising Therapeutic for Sepsis-Induced Acute Lung Injury

MANHASSET, N.Y.--(BUSINESS WIRE)--Scientists at Northwell Health’s Feinstein Institutes for Medical Research are making strides in controlling the severe inflammation that is the hallmark of sepsis. This severe condition occurs when the body’s immune system reaction to infection causes it to attack its own tissues and organs, often resulting in organ failure or death. Researchers have uncovered a critical mechanism driving acute lung injury (ALI) in sepsis, identifying a novel subset of neutrop...
Back to Newsroom